Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease. [electronic resource]
- Neurology Aug 2008
- 462; author reply 462-3 p. digital
Publication Type: Comment; Letter
1526-632X
10.1212/01.wnl.0000324506.93877.5e doi
Carbazoles--therapeutic use Cell Survival Disease Progression Humans JNK Mitogen-Activated Protein Kinases--antagonists & inhibitors Neurons--drug effects Neuroprotective Agents--therapeutic use Parkinson Disease--drug therapy Treatment Failure